Berko İlaç Establishes New Group

Berko İlaç established a new division dedicated to internal medicine and expanded its field teams. As a company known for career opportunities, Berko İlaç recruited approximately one hundred personnel with the establishment of its new division and expanded its organizational structure through internal appointments. During this process, recruitment focused primarily on experienced medical sales representatives, regional managers and product managers. Berko İlaç's 2020 target is to continue recruitment and employment at production facilities and central management. 2019 was a year in which Berko İlaç grew through factory investments, its R&D center, new products, export initiatives, revenue growth and new staff. Berko İlaç Board Chairman Ecz. Berat Beran said, "2019 was a year in which we continued to grow in all areas. We are proud that, particularly with the new division we established in the internal medicine branch and the employment we provided to approximately one hundred people, we have contributed to the national economy and Turkish medicine." Berko İlaç recently took the first steps toward a strategic partnership in the Balkans and signed a contract with Fufarma, an Albania-based company. Through this new partnership implemented in the Balkans, Berko İlaç aims to strengthen its export efforts and establish a joint structure that will generate revenue for Turkey.